AstraZeneca Tonocard discontinuation
Executive Summary
AstraZeneca will discontinue Tonocard (tocainide) in U.S. Dec. 31. Approved in 1984 to treat severe irregular heartbeat, company says newer products now dominate market. Tonocard was one of original Astra Merck collaborations (1"The Pink Sheet" Nov. 7, 1994, p. 9). Merck currently manufacturers the drug for AstraZeneca. Worldwide sales in 2002 were approximately $1.2 mil., the bulk of which were in the U.S, AstraZeneca says...